Surgery Partners (SGRY) reported second-quarter 2026 revenue of $848.9 million, up 2.7% from $826.2 million a year earlier. Net loss attributable to Surgery Partners, Inc. was $15.0 million for the quarter, and basic and diluted net loss per share attributable to common stockholders was $0.12.
The company reaffirmed its full-year 2026 revenue guidance of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, excluding the pending Idaho Falls divestiture.
- Revenue $848.9 million for Q2 2026, up 2.7% year over year.
- Same-facility revenue increased 5.0%, with same-facility cases up 0.3%.
- Net loss attributable to Surgery Partners was $15.0 million.
- Cash and cash equivalents totaled $216.7 million as of June 30, 2026.
- Operating cash flow was $59.3 million for the second quarter.
- Facilities totaled 178 surgical facilities at quarter-end, including 120 consolidated surgical facilities.
$SGRY Insider Trading Activity
$SGRY insiders have traded $SGRY stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $SGRY stock by insiders over the last 6 months:
- JASON ERIC EVANS (Chief Executive Officer) has made 0 purchases and 2 sales selling 31,862 shares for an estimated $412,448.
- DAVID T DOHERTY (Chief Financial Officer) has made 0 purchases and 2 sales selling 23,441 shares for an estimated $312,541.
- JENNIFER BALDOCK (Chief Admin & Dev Officer) has made 0 purchases and 2 sales selling 15,880 shares for an estimated $214,483.
- MARISSA BRITTENHAM (Chief Strategy Officer) has made 0 purchases and 2 sales selling 12,442 shares for an estimated $166,213.
- DANIELLE BURKHALTER (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 11,205 shares for an estimated $149,716.
- WILLIAM TRENTON WEBB (American Group President) has made 0 purchases and 2 sales selling 2,066 shares for an estimated $28,653.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SGRY Hedge Fund Activity
We have seen 102 institutional investors add shares of $SGRY stock to their portfolio, and 74 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 4,383,551 shares (-66.7%) from their portfolio in Q1 2026, for an estimated $52,251,927
- UBS GROUP AG added 2,387,807 shares (+30.6%) to their portfolio in Q1 2026, for an estimated $28,462,659
- NOMURA HOLDINGS INC removed 996,919 shares (-58.0%) from their portfolio in Q1 2026, for an estimated $11,883,274
- DAVIDSON KEMPNER CAPITAL MANAGEMENT LP added 965,000 shares (+40.7%) to their portfolio in Q1 2026, for an estimated $11,502,800
- VARDE MANAGEMENT, L.P. added 755,438 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,004,820
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 746,735 shares (-29.3%) from their portfolio in Q1 2026, for an estimated $8,901,081
- LMR PARTNERS LLP added 739,685 shares (+205.3%) to their portfolio in Q1 2026, for an estimated $8,817,045
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
